drugset / Trial / NCT02876159

The Immunologic Basis for an Attenuated Immune Response to the Influenza Vaccine After Repeated Annual Vaccination

NCT02876159 ↗

Phase 4 Completed 20 enrolled Emory University
Non-randomizedParallel-groupOpen-labelPrevention

Summary

This is a prospective pilot study designed to suggest differences in the immunologic response to the seasonal influenza vaccine in people with regular vaccination history compared to those vaccinated less regularly. Participants will receive one dose of the Food and Drug Administration (FDA) approved 2016-2017 seasonal influenza vaccine. Immune system data will be collected at standard time points. The duration of the study for each participant will be approximately 1 month.

Timeline

Start
2016-07
Primary completion
2016-10-18
Completion
2016-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject 2016-2017 Influenza Vaccine Vaccine 0.5 ml Intramuscular

Indications